- Home
- JG vs ECOR Comparison
JG vs ECOR Comparison
Compare JG & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JG
- ECOR
- Stock Information
- Founded
- JG 2012
- ECOR 2005
- Country
- JG China
- ECOR United States
- Employees
- JG N/A
- ECOR 62
- Industry
- JG Computer Software: Programming Data Processing
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JG Technology
- ECOR Health Care
- Exchange
- JG Nasdaq
- ECOR Nasdaq
- Market Cap
- JG 48.4M
- ECOR 39.6M
- IPO Year
- JG 2018
- ECOR 2018
- Fundamental
- Price
- JG $6.50
- ECOR $4.74
- Analyst Decision
- JG
- ECOR Strong Buy
- Analyst Count
- JG 0
- ECOR 2
- Target Price
- JG N/A
- ECOR $25.50
- AVG Volume (30 Days)
- JG 6.2K
- ECOR 39.5K
- Earning Date
- JG 11-13-2025
- ECOR 11-05-2025
- Dividend Yield
- JG N/A
- ECOR N/A
- EPS Growth
- JG N/A
- ECOR N/A
- EPS
- JG N/A
- ECOR N/A
- Revenue
- JG $48,999,972.00
- ECOR $27,700,000.00
- Revenue This Year
- JG $10.90
- ECOR $24.55
- Revenue Next Year
- JG N/A
- ECOR $41.13
- P/E Ratio
- JG N/A
- ECOR N/A
- Revenue Growth
- JG 18.82
- ECOR 30.16
- 52 Week Low
- JG $4.25
- ECOR $4.16
- 52 Week High
- JG $20.94
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- JG 27.87
- ECOR 42.03
- Support Level
- JG $5.85
- ECOR $4.88
- Resistance Level
- JG $8.55
- ECOR $5.17
- Average True Range (ATR)
- JG 0.35
- ECOR 0.24
- MACD
- JG -0.16
- ECOR -0.00
- Stochastic Oscillator
- JG 24.07
- ECOR 35.06
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.